Roche’s investigational obesity drug CT-388 delivers dramatic weight loss in Phase II trial
The Phase III programme, Enith1 and Enith2, is expected to launch this quarter
The Phase III programme, Enith1 and Enith2, is expected to launch this quarter
Gastrointestinal conditions affect millions across the UK, yet research in the field has often been fragmented, slow, or under-resourced
Treatment typically requires frequent injections directly into the eye—an ongoing burden for patients and health systems alike
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
The new facility offers an expanded laboratory alongside meeting areas dedicated to development meetings, formulation workshops, and brainstorming sessions
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
Heart failure affects an estimated 64.3 million people worldwide
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
Subscribe To Our Newsletter & Stay Updated